Men aged 50 years and older demonstrate insufficient knowledge, a positive attitude and proactive practices regarding benign prostatic hyperplasia (BPH), according to a study published online July 17 in Neurourology and Urodynamics.
Jul 30, 2026
0
266
A joint research team led by professors Sungsu Park of Sungkyunkwan University and Sun-Ha Paek of Seoul National University College of Medicine has demonstrated for the first time that the sequence in which immune cells interact ...
Jul 30, 2026
0
7
Neurons transmit information to the next cell by converting electrical signals into chemical signals. A critical step in this process is the influx of calcium ions into the cell through voltage-gated calcium channels. A research ...
Jul 30, 2026
0
5
Yoga is best known for improving flexibility, building strength and reducing stress. Research suggests it may also help ease symptoms of irritable bowel syndrome (IBS), a common digestive disorder that affects millions of ...
Jul 30, 2026
0
6
A major study has ruled out inflammation as the cause of a developmental condition affecting children's teeth while also revealing how common the condition is.
Jul 30, 2026
0
4
Researchers at Kennedy Krieger Institute and Penn Engineering have developed an advanced artificial intelligence system that measures a child's ability to imitate simple body movements using ordinary video recordings. The ...
Jul 30, 2026
0
6
When an adult sees a doctor and complains about persistent hip pain, the assumption is often wear-and-tear-related osteoarthritis. However, hip pain not caused by arthritis can come from conditions that are both more complex ...
Jul 30, 2026
0
143
The human gut harbors more than 40 trillion bacteria assembled into complex communities collectively known as the gut microbiota, which is closely linked to human health and disease. Mediterraneibacter gnavus (formerly Ruminococcus ...
Jul 30, 2026
0
26
Patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer experienced a 58% reduction in the risk of disease progression or death when treated with atezolizumab ...
Jul 30, 2026
0
7
The U.S. Food and Drug Administration has approved Simtriyo (centanafadine) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and children 6 years and older weighing ≥20 kg.
Jul 30, 2026
0
8
